Results show for the first time that CFE-RM reduces the negative effects of an atherogenic diet, improving glycemia, lipemia, AE activity, Ldlr levels and lipoprotein profiles by reducing the presence of β-VLDL, IDL and LDL which leads to a reduction in CDV risk. This evidence concerns the gene LDLR and hyperlipidemia.